UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000003197
Receipt No. R000003846
Scientific Title A Phase III Study Comparing Methotrexate, Adrimycin and Cisplatin (MAP) with MAP + Ifosfamide (MAP + IF) for the Treatment of Osteosarcoma (JCOG0905/OS-MAP + IF-P3)
Date of disclosure of the study information 2010/02/16
Last modified on 2016/05/02 13:35:49

No. Disposal Last modified on Item of update
1 Insert 2010/02/16 15:39:37
2 Update 2010/08/16 15:59:50 Name of person sending information
Name of person sending information
Institutions
3 Update 2012/05/28 14:45:28 Post marketing survey by drug manufacture etc., specified by Japanese law.
Institutions
4 Update 2013/08/12 15:05:12 Key exclusion criteria
Key exclusion criteria
5 Update 2013/08/12 15:16:41 Last follow-up date
6 Update 2014/06/27 14:11:57 Last name of lead principal investigator
Last name of lead principal investigator
TEL
Email
TEL
Institutions
7 Update 2014/06/27 14:15:40 Anticipated trial start date
Last follow-up date
8 Update 2016/05/02 13:32:07
Key inclusion criteria
Key inclusion criteria
Target sample size
9 Update 2016/05/02 13:35:04 Name of primary sponsor
Organization
Organization
Organization
Category of Funding Organization
Institutions
10 Update 2016/05/02 13:35:49 Last follow-up date


Contact us.